The latest study on Biosimilars/follow-on-biologics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Biosimilars/follow-on-biologics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Biosimilars/follow-on-biologics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Biosimilars/follow-on-biologics Market Analysis By Type Segment:
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
Biosimilars/follow-on-biologics Market Analysis By Application Segment:
Blood disorders
Oncology diseases
Chronic and autoimmune diseases
Growth hormone deficiencies
Others
Biosimilars/follow-on-biologics Market Analysis By Regions (Countries):
The Biosimilars/follow-on-biologics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Biosimilars/follow-on-biologics Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Biosimilars/follow-on-biologics Market:
Biosimilars/follow-on-biologics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Biosimilars/follow-on-biologics Market status and future forecast.
To present the key Biosimilars/follow-on-biologics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (2016-2027)
1.4.2 Human growth hormone
1.4.3 Erythropoietin
1.4.4 Monoclonal antibodies
1.4.5 Insulin
1.4.6 Interferon
1.4.7 Granulocyte-Colony Stimulating Factor
1.4.8 Others
1.5 Market by Application
1.5.1 Global Biosimilars/follow-on-biologics Market Share by Application (2016-2027)
1.5.2 Blood disorders
1.5.3 Oncology diseases
1.5.4 Chronic and autoimmune diseases
1.5.5 Growth hormone deficiencies
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Biosimilars/follow-on-biologics Market Size
2.2 Biosimilars/follow-on-biologics Growth Trends by Regions
2.2.1 Biosimilars/follow-on-biologics Market Size by Regions (2016-2027)
2.2.2 Biosimilars/follow-on-biologics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Biosimilars/follow-on-biologics Market Size by Manufacturers
3.1.1 Global Biosimilars/follow-on-biologics Revenue by Manufacturers (2020)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Manufacturers (2020)
3.1.3 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.2 Biosimilars/follow-on-biologics Key Players Head office and Area Served
3.3 Key Players Biosimilars/follow-on-biologics Product/Solution/Service
3.4 Date of Enter into Biosimilars/follow-on-biologics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Biosimilars/follow-on-biologics Market Size by Type (2016-2020)
4.2 Global Biosimilars/follow-on-biologics Market Size by Application (2016-2020)
5 United States
5.1 United States Biosimilars/follow-on-biologics Market Size (2016-2020)
5.2 Biosimilars/follow-on-biologics Key Players in United States
5.3 United States Biosimilars/follow-on-biologics Market Size by Type
5.4 United States Biosimilars/follow-on-biologics Market Size by Application
6 Europe
6.1 Europe Biosimilars/follow-on-biologics Market Size (2016-2020)
6.2 Biosimilars/follow-on-biologics Key Players in Europe
6.3 Europe Biosimilars/follow-on-biologics Market Size by Type
6.4 Europe Biosimilars/follow-on-biologics Market Size by Application
7 China
7.1 China Biosimilars/follow-on-biologics Market Size (2016-2020)
7.2 Biosimilars/follow-on-biologics Key Players in China
7.3 China Biosimilars/follow-on-biologics Market Size by Type
7.4 China Biosimilars/follow-on-biologics Market Size by Application
8 Japan
8.1 Japan Biosimilars/follow-on-biologics Market Size (2016-2020)
8.2 Biosimilars/follow-on-biologics Key Players in Japan
8.3 Japan Biosimilars/follow-on-biologics Market Size by Type
8.4 Japan Biosimilars/follow-on-biologics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2016-2020)
9.2 Biosimilars/follow-on-biologics Key Players in Southeast Asia
9.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type
9.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application
10 India
10.1 India Biosimilars/follow-on-biologics Market Size (2016-2020)
10.2 Biosimilars/follow-on-biologics Key Players in India
10.3 India Biosimilars/follow-on-biologics Market Size by Type
10.4 India Biosimilars/follow-on-biologics Market Size by Application
11 Central & South America
11.1 Central & South America Biosimilars/follow-on-biologics Market Size (2016-2020)
11.2 Biosimilars/follow-on-biologics Key Players in Central & South America
11.3 Central & South America Biosimilars/follow-on-biologics Market Size by Type
11.4 Central & South America Biosimilars/follow-on-biologics Market Size by Application
12 International Players Profiles
12.1 Novartis (Sandoz)
12.1.1 Novartis (Sandoz) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biosimilars/follow-on-biologics Introduction
12.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2020)
12.1.5 Novartis (Sandoz) Recent Development
12.2 Synthon Pharmaceuticals
12.2.1 Synthon Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biosimilars/follow-on-biologics Introduction
12.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2020)
12.2.5 Synthon Pharmaceuticals Recent Development
12.3 Teva Pharmaceutical Industries
12.3.1 Teva Pharmaceutical Industries Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biosimilars/follow-on-biologics Introduction
12.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2020)
12.3.5 Teva Pharmaceutical Industries Recent Development
12.4 LG Life Sciences
12.4.1 LG Life Sciences Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biosimilars/follow-on-biologics Introduction
12.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2020)
12.4.5 LG Life Sciences Recent Development
12.5 Celltrion Biocon
12.5.1 Celltrion Biocon Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biosimilars/follow-on-biologics Introduction
12.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2020)
12.5.5 Celltrion Biocon Recent Development
12.6 Hospira
12.6.1 Hospira Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biosimilars/follow-on-biologics Introduction
12.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2020)
12.6.5 Hospira Recent Development
12.7 Merck Serono (Merck)
12.7.1 Merck Serono (Merck) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biosimilars/follow-on-biologics Introduction
12.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2020)
12.7.5 Merck Serono (Merck) Recent Development
12.8 Biogen idec
12.8.1 Biogen idec Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biosimilars/follow-on-biologics Introduction
12.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2020)
12.8.5 Biogen idec Recent Development
12.9 Genentech (Roche)
12.9.1 Genentech (Roche) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biosimilars/follow-on-biologics Introduction
12.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2020)
12.9.5 Genentech (Roche) Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Biosimilars/follow-on-biologics Key Market Segments
Table Key Players Biosimilars/follow-on-biologics Covered
Table Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Type 2016-2027
Figure Human growth hormone Figures
Table Key Players of Human growth hormone
Figure Erythropoietin Figures
Table Key Players of Erythropoietin
Figure Monoclonal antibodies Figures
Table Key Players of Monoclonal antibodies
Figure Insulin Figures
Table Key Players of Insulin
Figure Interferon Figures
Table Key Players of Interferon
Figure Granulocyte-Colony Stimulating Factor Figures
Table Key Players of Granulocyte-Colony Stimulating Factor
Figure Others Figures
Table Key Players of Others
Table Global Biosimilars/follow-on-biologics Market Size Growth by Application 2016-2027 (Million US$)
Figure Blood disorders Case Studies
Figure Oncology diseases Case Studies
Figure Chronic and autoimmune diseases Case Studies
Figure Growth hormone deficiencies Case Studies
Figure Others Case Studies
Figure Biosimilars/follow-on-biologics Report Years Considered
Table Global Biosimilars/follow-on-biologics Market Size 2016-2027 (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size by Regions 2016-2027 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size by Regions 2016-2020 (Million US$)
Table Global Biosimilars/follow-on-biologics Market Share by Regions 2016-2020
Figure Global Biosimilars/follow-on-biologics Market Share by Regions 2016-2020
Figure Global Biosimilars/follow-on-biologics Market Share by Regions 2020
Table Market Top Trends
Table Global Biosimilars/follow-on-biologics Revenue by Manufacturers (2020) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Share by Manufacturers (2020)
Figure Global Biosimilars/follow-on-biologics Market Share by Manufacturers in 2020
Table Global Biosimilars/follow-on-biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Biosimilars/follow-on-biologics Product/Solution/Service
Table Date of Enter into Biosimilars/follow-on-biologics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size Share by Type (2016-2020)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Type (2016-2020)
Table Global Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table Global Biosimilars/follow-on-biologics Market Size Share by Application (2016-2020)
Figure Global Biosimilars/follow-on-biologics Market Size Market Share by Application (2016-2020)
Figure Global Biosimilars/follow-on-biologics Revenue Market Share by Application in 2020
Figure United States Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table United States Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table United States Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table United States Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table United States Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table United States Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table United States Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure Europe Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table Europe Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table Europe Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table Europe Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table Europe Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table Europe Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table Europe Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure China Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table China Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table China Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table China Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table China Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table China Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table China Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure Japan Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table Japan Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table Japan Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table Japan Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table Japan Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table Japan Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table Japan Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure Southeast Asia Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table Southeast Asia Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure India Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table India Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table India Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table India Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table India Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table India Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table India Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Figure Central & South America Biosimilars/follow-on-biologics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Biosimilars/follow-on-biologics Revenue (2020) (Million US$)
Table Central & South America Key Players Biosimilars/follow-on-biologics Market Share (2020)
Table Central & South America Biosimilars/follow-on-biologics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Biosimilars/follow-on-biologics Market Share by Type (2016-2020)
Table Central & South America Biosimilars/follow-on-biologics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Biosimilars/follow-on-biologics Market Share by Application (2016-2020)
Table Novartis (Sandoz) Company Details
Table Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2020) (Million US$)
Figure Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Novartis (Sandoz) Recent Development
Table Synthon Pharmaceuticals Company Details
Table Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Synthon Pharmaceuticals Recent Development
Table Teva Pharmaceutical Industries Company Details
Table Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Teva Pharmaceutical Industries Recent Development
Table LG Life Sciences Company Details
Table LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table LG Life Sciences Recent Development
Table Celltrion Biocon Company Details
Table Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Celltrion Biocon Recent Development
Table Hospira Company Details
Table Hospira Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Hospira Recent Development
Table Merck Serono (Merck) Company Details
Table Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Merck Serono (Merck) Recent Development
Table Biogen idec Company Details
Table Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Biogen idec Recent Development
Table Genentech (Roche) Company Details
Table Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2020)(Million US$)
Figure Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2020)
Table Genentech (Roche) Recent Development
Table Global Biosimilars/follow-on-biologics Market Size by Regions (Million US$) 2021-2027
Figure Global Biosimilars/follow-on-biologics Market Size Share by Regions (2021-2027)
Figure Global Biosimilars/follow-on-biologics Market Size Share by Regions in 2027
Figure United States Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure China Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure India Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Biosimilars/follow-on-biologics Market Size Forecast (2021-2027)(Million USD)
Table Global Biosimilars/follow-on-biologics Market Size by Product (2021-2027) (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size by Product (2021-2027)
Figure Global Biosimilars/follow-on-biologics Market Size by Product in 2027
Table Global Biosimilars/follow-on-biologics Market Size by Application (2021-2027) (Million US$)
Figure Global Biosimilars/follow-on-biologics Market Size by Application (2021-2027)
Figure Global Biosimilars/follow-on-biologics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources